R. R. da C. C. Bonadio, “Dose-dense versus 3-weekly ac during neoadjuvant chemoimmunotherapy for early-stage triple-negative breast cancer: GBECAM 0123 – the neo-real study”, MAST, vol. 34, no. suppl. 1, Mar. 2026.